Trial to Evaluate Steady State Pharmacokinetic Parameters, Efficacy and Safety of Nevirapine in Antiretroviral Drug naïve Pediatric Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
HIV Infections
Interventions
DRUG

Nevirapine

DRUG

Lamivudine

DRUG

Zidovudine

Trial Locations (4)

2013

Boehringer Ingelheim Investigational Site, Soweto

7505

Boehringer Ingelheim Investigational Site, Tygerberg

7900

Groote Schuur Hospital, Cape Town

Unknown

Boehringer Ingelheim Investigational Site, Pretoria

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY